CAPTRUST Financial Advisors
ARLZ

CAPTRUST Financial Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-509
Closed – – 5398
2022
Q1 		$0 Buy
+509
New – ﹤0.01% 5389

CAPTRUST Financial Advisors's ARLZ Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2022, closing a stake of 509 shares.

CAPTRUST Financial Advisors first reported a position in ARLZ in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 0 funds tracked by Wall St. Rank hold ARLZ as of Q2 2022.

  • CAPTRUST Financial Advisors reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 509 Aralez Pharmaceuticals Inc. shares in Q2 2022.
  • CAPTRUST Financial Advisors first reported a position in Aralez Pharmaceuticals Inc. in Q1 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Aralez Pharmaceuticals Inc. position peaked at $0 in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.